Security key
91864C107
Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS)
CUSIP: 91864C107
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / American Depositary Shares, each representing one ordinary share
- Total 13F shares
- 4,627,371
- Total 13F value
- $23,843,000
- Share change
- -274,221
- SEC-reported price per share
- $5.20
- Number of holders
- 10
- Value change
- -$1,912,073
- Number of buys
- 2
- Number of sells
- 8
- Shares outstanding
- 40,291,821
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2022
Institutions
10
Top holders
10
BRNS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Barinthus Biotherapeutics plc. SEC filings
Barinthus Biotherapeutics plc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 91864C107
Recent filing periods:
Ownership snapshot
Top reported holders of BRNS - Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Alphabet Inc.
Disclosed value leader
Alphabet Inc.
Comparable rows
14/15
Latest evidence
03 Jan 2022
13F
3/4/5
Lead comparable stake: 4.2%
1 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Alphabet Inc. leads the comparable SEC ownership view at 4.2%.
14 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Alphabet Inc.'s linked filing trail.
Comparable ownership
Top 5
Alphabet Inc.
4.2%
M&G INVESTMENT MANAGEMENT LTD
2.7%
DC Funds, LP
1.6%
Liontrust Investment Partners LLP
1.5%
BlueCrest Capital Management Ltd
1.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Alphabet Inc. |
13F
Company
|
4.2%
|
$18,935,000
1,704,344 shares
|
— | 31 Dec 2021 |
| M&G INVESTMENT MANAGEMENT LTD |
13F
Company
|
2.7%
|
$11,975,000
1,088,597 shares
|
— | 31 Dec 2021 |
| DC Funds, LP |
13F
Company
|
1.6%
|
$7,135,000
642,204 shares
|
— | 31 Dec 2021 |
| Liontrust Investment Partners LLP |
13F
Company
|
1.5%
|
$6,666,000
600,000 shares
|
— | 31 Dec 2021 |
| BlueCrest Capital Management Ltd |
13F
Company
|
1.3%
|
$6,034,000
543,073 shares
|
— | 31 Dec 2021 |
| Johns Hopkins University |
13F
Company
|
0.27%
|
$1,200,000
107,968 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
4,627,371
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q1 2026 Across Filers
Q1 2026 holders
14
Q1 2022 holders
10
Holder diff
-4
| Investor | Q1 2026 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend